Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

194.09 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	194.09
Bid (Size)	192.00 (100)
Ask (Size)	196.50 (100)
Prev. Close	194.09
Today's Range	194.09 - 194.09
52wk Range	100.99 - 198.87
Shares Outstanding	55,679,964
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Reasons to Avoid RGEN and 1 Stock to Buy Instead

September 09, 2026

Over the past six months, Repligen has been a great trade, beating the S&P 500 by 18.1%. Its stock price has climbed to $168.43, representing a healthy 31.7%...

Via StockStory

Repligen Corp (NASDAQ:RGEN) Combines Strong Growth with a Constructive Technical Setup ↗

September 05, 2026

Via Chartmill

Performance

YTD	+18.1%	+18.1%
1 Month	+7.2%	+7.2%
3 Month	+41.7%	+41.7%
6 Month	+74.1%	+74.1%
1 Year	+56.4%	+56.4%

More News

1 Profitable Stock on Our Buy List and 2 We Brush Off

August 28, 2026

Via StockStory

3 High-Flying Stocks with Warning Signs

August 24, 2026

Via StockStory

3 Hyped Up Stocks We Keep Off Our Radar

August 21, 2026

Via StockStory

Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup ↗

July 30, 2026

Via Chartmill

Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat ↗

July 28, 2026

Via Chartmill

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks

August 16, 2026

Via StockStory

2 Growth Stocks to Add to Your Roster and 1 We Avoid

August 13, 2026

Via StockStory

Why Repligen (RGEN) Stock Is Up Today

July 28, 2026

Via StockStory

Repligen Q2 Earnings Call Highlights ↗

July 28, 2026

Via MarketBeat

Which stocks are gapping on Tuesday? ↗

July 28, 2026

Via Chartmill

Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026

July 28, 2026

Via StockStory

Repligen (RGEN) Q2 Earnings: What To Expect

July 26, 2026

Via StockStory

Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know

July 24, 2026

Via StockStory

3 Cash-Producing Stocks That Concern Us

July 24, 2026

Via StockStory

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach ↗

July 22, 2026

Via MarketBeat

Why Repligen (RGEN) Stock Is Trading Lower Today

July 21, 2026

Via StockStory

3 Reasons RGEN is Risky and 1 Stock to Buy Instead

July 08, 2026

Via StockStory

2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

June 25, 2026

Via StockStory

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

June 19, 2026

Via StockStory

3 Out-of-Favor Stocks We Keep Off Our Radar

May 22, 2026

Via StockStory

Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

May 18, 2026

Via StockStory

Why Repligen (RGEN) Stock Is Trading Up Today

May 15, 2026

Via StockStory

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

May 15, 2026

Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?

Yes, Repligen Corporation - Common Stock is publicly traded.

What exchange does Repligen Corporation - Common Stock trade on?

Repligen Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Repligen Corporation - Common Stock?

The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market

What is the current price of Repligen Corporation - Common Stock?

The current price of Repligen Corporation - Common Stock is 194.09

When was Repligen Corporation - Common Stock last traded?

The last trade of Repligen Corporation - Common Stock was at 09/28/26 04:00 PM ET

What is the market capitalization of Repligen Corporation - Common Stock?

The market capitalization of Repligen Corporation - Common Stock is 10.81B

How many shares of Repligen Corporation - Common Stock are outstanding?

Repligen Corporation - Common Stock has 11B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.